Aurinia Pharmaceuticals Inc. (AUPH)

29.92
NASDAQ
Prev Close 30.35
Day Low/High 28.50 / 30.50
52 Wk Low/High 9.72 / 30.95
Exchange NASDAQ
Shares Outstanding 128.40B
Market Cap 3.90B
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

I Have 14 Key Stocks on My Shopping List

I Have 14 Key Stocks on My Shopping List

My positions change very fast and I'm actively trading all these names.

10 Good-Looking Small-Cap Stocks as Markets Mildly Correct

10 Good-Looking Small-Cap Stocks as Markets Mildly Correct

The process of closing the gap between large-caps and secondary stocks may be starting today.

Here's How I'd React to a Selloff on Jackson Hole

Here's How I'd React to a Selloff on Jackson Hole

The move on Thursday wasn't as much a surprise as it would seem, but now we must look to what could happen next.

Lethargic Indices Mask a Spark in Smaller Gaming Stocks

Lethargic Indices Mask a Spark in Smaller Gaming Stocks

A number of gambling stocks are up on word that DraftKings plans to buy Golden Nugget Online Gaming.

Aurinia Pharmaceuticals' Charts Are Showing Side Effects

Aurinia Pharmaceuticals' Charts Are Showing Side Effects

Here's what to avoid.

I'm Looking for Some Mild Pullbacks to Create Another Round of Setups

I'm Looking for Some Mild Pullbacks to Create Another Round of Setups

There are plenty of small-caps that have finally bounced and are now consolidating.

The Indices and Broader Markets Need Much More Work to Hit a Good Low

The Indices and Broader Markets Need Much More Work to Hit a Good Low

Much of the action has to do with the disconnect recently between the indices and the vast majority of individual stocks.

The Good News Is That the Overall Price Action Is Positive

The Good News Is That the Overall Price Action Is Positive

We're going to see some random action in front of the weekend.

It's Time for a Bit of Repositioning as Another Earnings Season Approaches

It's Time for a Bit of Repositioning as Another Earnings Season Approaches

The end of the quarter means a new round of quarterly reports is near, so it pays to keep an eye on favorite names.

The Market Turns on News of Delta Variant, Russell Indexing

The Market Turns on News of Delta Variant, Russell Indexing

Technology strengthens, while the Dow Jones industrial average and Russell 2000 lag.

Stock Picking Remains the Name of the Game

Stock Picking Remains the Name of the Game

The tricky part is that sector strength is shifting fast.

It Is a Dull Market, but Here Are Several Names I'm Trading

It Is a Dull Market, but Here Are Several Names I'm Trading

Action like this sometimes leads to a 'don't short a dull market' response.

My Impression Now Is That Market Players Lack Energy

My Impression Now Is That Market Players Lack Energy

I don't want to sound negative as it's a major positive that there isn't aggressive downside follow through.

Focus on the Price Action, and Avoid the Perma-Pessimists

Focus on the Price Action, and Avoid the Perma-Pessimists

Stocks with good charts, good fundamentals, and good stories are attracting buyers.

This Picker's on the Prowl: Here's What I'm Trading

This Picker's on the Prowl: Here's What I'm Trading

I've been very busy making some quick trades.

Keep an Eye on Biotech and Cryptos as the Weekend Approaches

Keep an Eye on Biotech and Cryptos as the Weekend Approaches

There's one name I've added to today.

Long-Suffering Biotech May Be Hitting a Bottom

Long-Suffering Biotech May Be Hitting a Bottom

Here are some biotech and gaming names I am watching as these sectors begin to rotate.

Biotechs Are One of the Few Positives in This Ugly Market

Biotechs Are One of the Few Positives in This Ugly Market

Of 56 recent ARKK buys, only two are trading in positive territory Wednesday.

The Selling Pressure on Many Stocks Is Brutal

The Selling Pressure on Many Stocks Is Brutal

The good news is that this sort of action always eventually leads to great stock picking.

It's a Strange Mix of Action Out There

It's a Strange Mix of Action Out There

The best momentum on my screens right now are the U.S. cannabis plays that are referred to as Multi-State Operators.

Pockets of Momentum Remain Very Narrow

Pockets of Momentum Remain Very Narrow

There continues to be little energy among stock pickers.

My Game Plan as We Wait for Small-Caps to Follow Through

My Game Plan as We Wait for Small-Caps to Follow Through

It is premature to declare the rotation back into small-cap stocks is dead.

Small-Caps Are Finally Showing Some Relative Strength

Small-Caps Are Finally Showing Some Relative Strength

I'm feeling better about more aggressive stock picking, but I'm staying selective.

The Art of the Remount

The Art of the Remount

Rebuying a stock that you have previously sold can be an extremely powerful trading strategy.

The Markets Are Steadily Climbing

The Markets Are Steadily Climbing

I'm hoping that we see some more rotational action rather than a broad market correction.

How to Bottom Fish

How to Bottom Fish

Here's my three-point guide -- with a focus on the biotechs.

Making the Best of the Peculiar Market Action

Making the Best of the Peculiar Market Action

Trading in biotech stocks and a particular SPAC play are on my mind.

16 Biotechs I Like Even as a Lack of Liquidity Is Hurting the Market

16 Biotechs I Like Even as a Lack of Liquidity Is Hurting the Market

Quite a few stocks are fading right now -- not due to poor fundamentals, but due to lack of buying interest.